H1B Atlas
TP
PERM FY2024-FY2025NAICS 325412

Tris Pharma, Inc. PERM Filings

Public PERM filing activity, approval signal, filed wage evidence, beneficiary countries, law firms, and role mix for Tris Pharma, Inc..

Updated 2026-05-23
View H-1B profile

PERM filings

8records

Approval rate

62.5%FY2024-FY2025

Median filed wage

$109,474base wage

Denied filings

0PERM records

Top country

CHINA1 filings
LCA filings are not visa approvals or open roles — see why this matters
Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally use the lower bound of filed wage ranges and exclude equity, bonus, and benefits. PERM pages describe employer filing activity and should not be read as legal advice or a prediction of an individual case outcome.

PERM filings over time

Annual PERM filing counts across available fiscal years.

FY2024FY2025
FY2024: 2FY2025: 6

Top PERM roles

  • Sr. Scientist I, Method Validation3
    $113,318
  • QC Lab Operation Chemist3
    $78,374
  • Technical Services Engineer - Scientist III1
    $147,846
  • QC Lab Operations Specialist1
    $113,318

Top beneficiary countries

  • CHINA1
  • INDIA1

Top law firms

  • Law Offices of Kendra S. Kembel, Esq.6
  • Kendra S Kembel2

Frequently Asked Questions

How many PERM filings does Tris Pharma, Inc. have?
Tris Pharma, Inc. has 8 PERM filings in the available FY2024-FY2025 dataset.
What is the PERM approval rate for Tris Pharma, Inc.?
The observed PERM approval rate for Tris Pharma, Inc. is 62.5% based on certified and denied filings in the available dataset.
Which PERM roles appear most often for Tris Pharma, Inc.?
Common PERM roles for Tris Pharma, Inc. include Sr. Scientist I, Method Validation, QC Lab Operation Chemist, Technical Services Engineer - Scientist III.
Which beneficiary countries appear most often in Tris Pharma, Inc. PERM filings?
Common beneficiary countries in Tris Pharma, Inc. PERM filings include CHINA, INDIA.